Carboxyamidotriazole Synergizes with Sorafenib to Combat Non-Small Cell Lung Cancer through Inhibition of NANOG and Aggravation of Apoptosis

The Journal of Pharmacology and Experimental Therapeutics
Chen ChenLei Guo

Abstract

Lung cancer is currently the leading cause of cancer-related deaths worldwide. In this study, we investigated the combination of carboxyamidotriazole (CAI) and sorafenib in non-small cell lung cancer (NSCLC) in vitro and in vivo to test whether CAI enhances the antitumor effects of sorafenib and reduces its side effects. The combination index (CI) showed that coadministration of CAI and sorafenib synergistically inhibited the proliferation of NSCLC cells (Lewis lung carcinoma, A549, and NCI-H1975 cells). Cell death as a result of the combination treatment was attributed to apoptosis, which was accompanied by activation of caspase-3 and poly(ADP-ribose) polymerase. In addition, combination therapy induced the accumulation of mitochondrial-associated reactive oxygen species, as well as depolarization of mitochondrial and reduced NANOG (homeobox protein NANOG) mRNA and protein expression. Basic fibroblast growth factor, a stimulator of NANOG, was applied to identify the possible mechanism. The addition of basic fibroblast growth factor followed by combined treatment may stimulate NANOG expression and synchronously rescue the accumulation of reactive oxygen species. C57BL/6J mice bearing Lewis lung carcinoma were randomized to rece...Continue Reading

References

Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BerlinG Wilding
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E C KohnE Reed
Mar 21, 2001·Apoptosis : an International Journal on Programmed Cell Death·H U SimonF Levi-Schaffer
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mahrukh M HussainElise C Kohn
Aug 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey W ClarkHeinz-Josef Lenz
Oct 4, 2006·Nature Reviews. Drug Discovery·Scott WilhelmSusan Kelley
Feb 14, 2007·The Oncologist·Cesare GridelliAntonio Rossi
Apr 5, 2007·Nature Protocols·Vanicha Vichai, Kanyawim Kirtikara
Oct 10, 2007·Journal of Cellular Physiology·Riccardo AlessandroGiacomo De Leo
Nov 30, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Elizabeth A JohnsonEdith A Perez
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George R BlumenscheinMartin Reck
Jan 20, 2011·Molecular and Cellular Biochemistry·Yan-Li LinHong-Xing Chen
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Apr 5, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Juanjuan ShanCheng Qian
Sep 18, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Heather A WakeleeJoan H Schiller
Sep 11, 2013·Surgical Oncology·Yaming DuTianyi Wang
May 28, 2015·Molecular Carcinogenesis·Shuai GongBigang Liu
Mar 5, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chen ShenJi Hyun Park
Aug 31, 2016·Lancet·Fred R HirschLuis Paz-Ares
Jan 27, 2017·Naunyn-Schmiedeberg's Archives of Pharmacology·Chen ChenLei Guo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis